Page 1 of 45
LLU NA Pharm 1 * Exam 1 💊 Part 3 📈
Pharmacodynamics & Pharmacokinetics Exam
With Correct Answers,Rationales Newest 2026
Exam Verified 100 %
Which of the following correctly describes a key difference between
competitive and noncompetitive antagonists?
A. Noncompetitive antagonists increase agonist potency
B. Competitive antagonists reduce the maximum efficacy of the agonist
C. Competitive antagonists bind irreversibly to the receptor
D. Noncompetitive antagonists cannot be overcome by increasing agonist
concentration
Correct Answer:D. Noncompetitive antagonists cannot be overcome by increasing
agonist concentration
Rationale:Noncompetitive antagonists typically bind irreversibly or at an allosteric
site, reducing the maximal effect of an agonist regardless of dose. Competitive
antagonism, on the other hand, is reversible with higher agonist doses.
Which term refers to the ability of a drug to activate a receptor and produce a
maximal biological response?
A. Potency
B. Efficacy
C. Bioavailability
D. Affinity
Correct Answer:B. Efficacy
Rationale:Efficacy describes the maximal effect a drug can produce, regardless of
dose. It reflects the drug’s intrinsic activity at the receptor.
, Page 2 of 45
Drug A has a steep concentration-effect slope, while Drug B has a flatter slope.
Which statement best describes the clinical implication of this difference?
A. Drug A requires larger dose increases to produce an effect
B. Drug B has a higher risk of toxicity with small dose changes
C. Drug A produces large changes in effect with small changes in dose
D. Drug B is more potent than Drug A due to its flatter slope
Correct Answer: C. Drug A produces large changes in effect with small changes in
dose
Rationale: A steep slope means high sensitivity to dose changes — even small
increases can result in large effects, which is common with drugs like opioids.
What happens to the therapeutic index when the TD50 is close to the ED50?
A. The drug becomes more effective
B. The therapeutic index increases
C. The therapeutic index decreases
D. The drug requires no monitoring
Correct Answer:C. The therapeutic index decreases
Rationale:A small difference between the toxic dose (TD50) and effective dose
(ED50) results in a low therapeutic index, indicating increased risk for toxicity and
narrow safety margin.
Which of the following terms describes a compound that produces the
opposite effect of an agonist at the same receptor?
A. Noncompetitive antagonist
B. Inverse agonist
C. Partial agonist
D. Allosteric modulator
Correct Answer:B. Inverse agonist
Rationale:Inverse agonists bind to the same receptor as agonists but stabilize the
inactive conformation, resulting in effects opposite to those of agonists.
Which of the following correctly describes one of the four main types of drug
interactions?
A. Addition – the combined effect is greater than the sum of individual effects
B. Synergism – one drug inactivates the other completely
C. Potentiation – one drug enhances the effect of another even though it has
no effect on its own
, Page 3 of 45
D. Antagonism – both drugs have the same mechanism and intensify the same
response
Correct Answer: C. Potentiation – one drug enhances the effect of another even
though it has no effect on its own
Rationale: Potentiation refers to the interaction where one drug (which may not have
any effect by itself) increases the effect of another drug. The other choices
misrepresent the correct definitions of interaction types.
What best describes the mechanism of action of a non-competitive
antagonist?
A. Binds reversibly to the orthosteric site and can be displaced by high
concentrations of an agonist.
B. Binds irreversibly to the orthosteric site or to an allosteric site, reducing the
maximum response regardless of agonist concentration.
C. Binds reversibly to the allosteric site and increases the effect of an agonist.
D. Competes with the agonist at the active site but produces a partial response
when bound.
Correct Answer:B. Binds irreversibly to the orthosteric site or to an allosteric site,
reducing the maximum response regardless of agonist concentration.
Rationale:Non-competitive antagonists do not compete directly with agonists at the
orthosteric site. They bind irreversibly (often via covalent bonds) or bind to allosteric
sites that modulate receptor activity, and their inhibition cannot be overcome by
increasing agonist concentrations
Which statement best describes the concept of "spare receptors" in
pharmacodynamics?
A. All receptors must be occupied to produce maximal tissue response.
B. Only antagonists can demonstrate spare receptor effects.
C. A maximal response can be achieved without full receptor occupancy due
to signal amplification.
D. The concept of spare receptors applies only to irreversible antagonists.
Correct Answer:C. A maximal response can be achieved without full receptor
occupancy due to signal amplification.
Rationale:Spare receptor theory suggests that not all receptors need to be occupied
to achieve a maximal tissue response. This is often due to intracellular signal
, Page 4 of 45
amplification where only a small percentage of activated receptors can generate a
full response
Succinylcholine acts as a depolarizing neuromuscular blocker primarily
because it:
A. Binds to muscarinic M2 receptors in the heart to reduce muscle tone.
B. Inhibits acetylcholinesterase, allowing acetylcholine to accumulate.
C. Binds to nicotinic acetylcholine receptors, causes depolarization, and
remains bound, preventing repolarization.
D. Blocks sodium channels in skeletal muscle directly without receptor
binding.
Correct Answer:C. Binds to nicotinic acetylcholine receptors, causes depolarization,
and remains bound, preventing repolarization.
Rationale:Succinylcholine resembles two acetylcholine molecules and binds to
nicotinic receptors at the neuromuscular junction, causing the receptor to open and
depolarize the muscle. However, it is not degraded as rapidly as acetylcholine, so it
keeps the receptor in an open state, preventing repolarization, leading to paralysis
According to the law of mass action in drug-receptor interactions, which factor
increases the probability of receptor occupancy?
A. Increasing receptor recycling
B. Increasing the number of allosteric sites
C. Increasing the concentration of drug and available receptors
D. Increasing the metabolism of the drug
Correct Answer:C. Increasing the concentration of drug and available receptors
Rationale:The law of mass action explains that the magnitude of drug response is
proportional to the number of drug-receptor complexes. Higher drug concentration
and more receptors increase the chance of binding and therefore tissue response
Which interaction type is primarily responsible for the reversible binding of
most anesthetic agents to their receptors?
A. Covalent
B. Ionic
C. Hydrogen
D. Van der Waals
Correct Answer:D. Van der Waals
LLU NA Pharm 1 * Exam 1 💊 Part 3 📈
Pharmacodynamics & Pharmacokinetics Exam
With Correct Answers,Rationales Newest 2026
Exam Verified 100 %
Which of the following correctly describes a key difference between
competitive and noncompetitive antagonists?
A. Noncompetitive antagonists increase agonist potency
B. Competitive antagonists reduce the maximum efficacy of the agonist
C. Competitive antagonists bind irreversibly to the receptor
D. Noncompetitive antagonists cannot be overcome by increasing agonist
concentration
Correct Answer:D. Noncompetitive antagonists cannot be overcome by increasing
agonist concentration
Rationale:Noncompetitive antagonists typically bind irreversibly or at an allosteric
site, reducing the maximal effect of an agonist regardless of dose. Competitive
antagonism, on the other hand, is reversible with higher agonist doses.
Which term refers to the ability of a drug to activate a receptor and produce a
maximal biological response?
A. Potency
B. Efficacy
C. Bioavailability
D. Affinity
Correct Answer:B. Efficacy
Rationale:Efficacy describes the maximal effect a drug can produce, regardless of
dose. It reflects the drug’s intrinsic activity at the receptor.
, Page 2 of 45
Drug A has a steep concentration-effect slope, while Drug B has a flatter slope.
Which statement best describes the clinical implication of this difference?
A. Drug A requires larger dose increases to produce an effect
B. Drug B has a higher risk of toxicity with small dose changes
C. Drug A produces large changes in effect with small changes in dose
D. Drug B is more potent than Drug A due to its flatter slope
Correct Answer: C. Drug A produces large changes in effect with small changes in
dose
Rationale: A steep slope means high sensitivity to dose changes — even small
increases can result in large effects, which is common with drugs like opioids.
What happens to the therapeutic index when the TD50 is close to the ED50?
A. The drug becomes more effective
B. The therapeutic index increases
C. The therapeutic index decreases
D. The drug requires no monitoring
Correct Answer:C. The therapeutic index decreases
Rationale:A small difference between the toxic dose (TD50) and effective dose
(ED50) results in a low therapeutic index, indicating increased risk for toxicity and
narrow safety margin.
Which of the following terms describes a compound that produces the
opposite effect of an agonist at the same receptor?
A. Noncompetitive antagonist
B. Inverse agonist
C. Partial agonist
D. Allosteric modulator
Correct Answer:B. Inverse agonist
Rationale:Inverse agonists bind to the same receptor as agonists but stabilize the
inactive conformation, resulting in effects opposite to those of agonists.
Which of the following correctly describes one of the four main types of drug
interactions?
A. Addition – the combined effect is greater than the sum of individual effects
B. Synergism – one drug inactivates the other completely
C. Potentiation – one drug enhances the effect of another even though it has
no effect on its own
, Page 3 of 45
D. Antagonism – both drugs have the same mechanism and intensify the same
response
Correct Answer: C. Potentiation – one drug enhances the effect of another even
though it has no effect on its own
Rationale: Potentiation refers to the interaction where one drug (which may not have
any effect by itself) increases the effect of another drug. The other choices
misrepresent the correct definitions of interaction types.
What best describes the mechanism of action of a non-competitive
antagonist?
A. Binds reversibly to the orthosteric site and can be displaced by high
concentrations of an agonist.
B. Binds irreversibly to the orthosteric site or to an allosteric site, reducing the
maximum response regardless of agonist concentration.
C. Binds reversibly to the allosteric site and increases the effect of an agonist.
D. Competes with the agonist at the active site but produces a partial response
when bound.
Correct Answer:B. Binds irreversibly to the orthosteric site or to an allosteric site,
reducing the maximum response regardless of agonist concentration.
Rationale:Non-competitive antagonists do not compete directly with agonists at the
orthosteric site. They bind irreversibly (often via covalent bonds) or bind to allosteric
sites that modulate receptor activity, and their inhibition cannot be overcome by
increasing agonist concentrations
Which statement best describes the concept of "spare receptors" in
pharmacodynamics?
A. All receptors must be occupied to produce maximal tissue response.
B. Only antagonists can demonstrate spare receptor effects.
C. A maximal response can be achieved without full receptor occupancy due
to signal amplification.
D. The concept of spare receptors applies only to irreversible antagonists.
Correct Answer:C. A maximal response can be achieved without full receptor
occupancy due to signal amplification.
Rationale:Spare receptor theory suggests that not all receptors need to be occupied
to achieve a maximal tissue response. This is often due to intracellular signal
, Page 4 of 45
amplification where only a small percentage of activated receptors can generate a
full response
Succinylcholine acts as a depolarizing neuromuscular blocker primarily
because it:
A. Binds to muscarinic M2 receptors in the heart to reduce muscle tone.
B. Inhibits acetylcholinesterase, allowing acetylcholine to accumulate.
C. Binds to nicotinic acetylcholine receptors, causes depolarization, and
remains bound, preventing repolarization.
D. Blocks sodium channels in skeletal muscle directly without receptor
binding.
Correct Answer:C. Binds to nicotinic acetylcholine receptors, causes depolarization,
and remains bound, preventing repolarization.
Rationale:Succinylcholine resembles two acetylcholine molecules and binds to
nicotinic receptors at the neuromuscular junction, causing the receptor to open and
depolarize the muscle. However, it is not degraded as rapidly as acetylcholine, so it
keeps the receptor in an open state, preventing repolarization, leading to paralysis
According to the law of mass action in drug-receptor interactions, which factor
increases the probability of receptor occupancy?
A. Increasing receptor recycling
B. Increasing the number of allosteric sites
C. Increasing the concentration of drug and available receptors
D. Increasing the metabolism of the drug
Correct Answer:C. Increasing the concentration of drug and available receptors
Rationale:The law of mass action explains that the magnitude of drug response is
proportional to the number of drug-receptor complexes. Higher drug concentration
and more receptors increase the chance of binding and therefore tissue response
Which interaction type is primarily responsible for the reversible binding of
most anesthetic agents to their receptors?
A. Covalent
B. Ionic
C. Hydrogen
D. Van der Waals
Correct Answer:D. Van der Waals
